Literature DB >> 16538870

Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.

Manuel López-Cabrera1, Abelardo Aguilera, Luiz S Aroeira, Marta Ramírez-Huesca, M Luisa Pérez-Lozano, José A Jiménez-Heffernan, M Auxiliadora Bajo, Gloria del Peso, José A Sánchez-Tomero, Rafael Selgas.   

Abstract

During peritoneal dialysis (PD), the peritoneum is exposed to bioincompatible dialysis fluids, which causes progressive fibrosis and angiogenesis and, ultimately, ultrafiltration failure. In addition, repeated episodes of peritonitis or hemoperitoneum may accelerate all these processes. Fibrosis has been classically considered the main cause of peritoneal membrane functional decline. However, in parallel with fibrosis, the peritoneum also displays increases in capillary number (angiogenesis) and vasculopathy in response to PD. Nowadays, there is emerging evidence pointing to peritoneal microvasculature as the main factor responsible for increased solute transport and ultrafiltration failure. However, the pathophysiologic mechanism(s) involved in starting and maintaining peritoneal fibrosis and angiogenesis remain(s) elusive. Peritoneal stromal fibroblasts have been considered (for many years) the cell type mainly involved in structural and functional alterations of the peritoneum; whereas mesothelial cells have been considered mere victims of peritoneal injury caused by PD. Recently, ex vivo cultures of effluent-derived mesothelial cells, in conjunction with immunohistochemical analysis of peritoneal biopsies from PD patients, have identified mesothelial cells as culprits, at least in part, in peritoneal membrane deterioration. This review discusses recent findings that suggest new peritoneal myofibroblastic cells may arise from local conversion of mesothelial cells by epithelial-to-mesenchymal transition during the repair responses that take place in PD. The transdifferentiated mesothelial cells may retain a permanent mesenchymal state, as long as initiating stimuli persist, and contribute to PD-induced fibrosis and angiogenesis, and hence to membrane failure. Future therapeutic interventions could be designated in order to prevent or reverse epithelial-to-mesenchymal transition of mesothelial cells, or its pernicious effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538870

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  26 in total

1.  miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.

Authors:  Marta Fierro-Fernández; Óscar Busnadiego; Pilar Sandoval; Cristina Espinosa-Díez; Eva Blanco-Ruiz; Macarena Rodríguez; Héctor Pian; Ricardo Ramos; Manuel López-Cabrera; Maria Laura García-Bermejo; Santiago Lamas
Journal:  EMBO Rep       Date:  2015-08-27       Impact factor: 8.807

2.  Characterization of peritoneal dialysis effluent-derived cells: diagnosis of peritoneal integrity.

Authors:  Yo Higashi; Koji Abe; Tomoaki Kuzumoto; Takuya Hara; Keiichi Miyamoto; Tomohiro Murata; Eiji Ishikawa; Shinsuke Nomura; Takashi Horiuchi
Journal:  J Artif Organs       Date:  2012-12-30       Impact factor: 1.731

3.  Influence of bicarbonate/low-GDP peritoneal dialysis fluid (BicaVera) on in vitro and ex vivo epithelial-to-mesenchymal transition of mesothelial cells.

Authors:  Antonio Fernández-Perpén; María Luisa Pérez-Lozano; María-Auxiliadora Bajo; Patricia Albar-Vizcaino; Pilar Sandoval Correa; Gloria del Peso; María-José Castro; Abelardo Aguilera; Marta Ossorio; Mirjam E Peter; Jutta Passlick-Deetjen; Luiz S Aroeira; Rafael Selgas; Manuel López-Cabrera; J Antonio Sánchez-Tomero
Journal:  Perit Dial Int       Date:  2012-01-03       Impact factor: 1.756

4.  Alterations of intercellular junctions in peritoneal mesothelial cells from patients undergoing dialysis: effect of retinoic Acid.

Authors:  Carmen Retana; Elsa Sanchez; Alejandro Perez-Lopez; Armando Cruz; Jesus Lagunas; Carmen Cruz; Socorro Vital; Jose L Reyes
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

Review 5.  Pathogenesis and treatment of peritoneal membrane failure.

Authors:  Ramesh Saxena
Journal:  Pediatr Nephrol       Date:  2007-09-21       Impact factor: 3.714

6.  Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway.

Authors:  Raffaele Strippoli; Ignacio Benedicto; Maria Luisa Pérez Lozano; Ana Cerezo; Manuel López-Cabrera; Miguel A del Pozo
Journal:  Dis Model Mech       Date:  2008-10-28       Impact factor: 5.758

7.  A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis.

Authors:  Oscar Busnadiego; Jesús Loureiro-Álvarez; Pilar Sandoval; David Lagares; Javier Dotor; María Luisa Pérez-Lozano; María J López-Armada; Santiago Lamas; Manuel López-Cabrera; Fernando Rodríguez-Pascual
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

8.  Peritoneal microvascular endothelial function and the microinflammatory state are associated with baseline peritoneal transport characteristics in uremic patients.

Authors:  Lanbo Teng; Ming Chang; Shuxin Liu; Min Niu; Yungang Zhang; Xiangfei Liu; Xiaoxia Yu
Journal:  Int Urol Nephrol       Date:  2014-07-08       Impact factor: 2.370

9.  Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane.

Authors:  Luiz S Aroeira; Enrique Lara-Pezzi; Jesús Loureiro; Abelardo Aguilera; Marta Ramírez-Huesca; Guadalupe González-Mateo; M Luisa Pérez-Lozano; Patricia Albar-Vizcaíno; M-Auxiliadora Bajo; Gloria del Peso; José Antonio Sánchez-Tomero; José Antonio Jiménez-Heffernan; Rafael Selgas; Manuel López-Cabrera
Journal:  J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 10.121

10.  Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.

Authors:  Jesús Loureiro; Pilar Sandoval; Gloria del Peso; Guadalupe Gónzalez-Mateo; Vanessa Fernández-Millara; Beatríz Santamaria; Maria Auxiliadora Bajo; José Antonio Sánchez-Tomero; Gonzalo Guerra-Azcona; Rafael Selgas; Manuel López-Cabrera; Abelardo I Aguilera
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.